| Summary: | Positron emission tomography-computed tomography (PET-CT) is an advanced nuclear imaging technique that combines a positron emission tomography (PET) scanner and an X-ray computed tomography scanner (CT) into a single machine. PET-CT is primarily used in oncology to diagnose and stage various types of cancers. However, over the past decade, their use has expanded from oncology to a variety of other disciplines including cardiology. Within Canada, there is growing interest in expanding public funding for PET-CT for cardiac indications, with some jurisdictions providing access to PET-CT for the assessment of myocardial viability, myocardial perfusion, and sarcoidosis. The perspectives of patients and their caregivers can support decision making around public provision of PET-CT for cardiac indications by identifying patients' preferences, values, and the context in which they seek care. The purpose of this report is to identify and describe patients' and caregivers' experiences and perspectives on PET-CT for cardiac indications
|
|---|